Luminespib

N/A

Report date: 2024/10/16 20:01:12
NME

Base Information

Drug NameLuminespib
Drug Alias Nameluminespibum芦米司匹鲁奈司匹NVP-AUY-922NVP-AUY-922-NX +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock protein HSP90 inhibitors
TargetsHeat shock protein HSP90
Therapy Area/IndicationsMetastatic breast cancerGastroesophageal Junction NeoplasmsSolid tumours +[15] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[22] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaPending
Originator CompaniesVernalis Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Health Research InstitutesNovartis Pharma AgTexas Tech University Health Sciences Center El Paso +[11] 
Active IndicationsN/A
Inactive IndicationsMetastatic breast cancerGastroesophageal Junction NeoplasmsSolid tumours +[15] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG